XFOR · X4 Pharmaceuticals, Inc

$4.00 +0.07 (+1.78%)

Market Cap

$370.68M

94.32M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Adam R. Craig	Chairman	$179,629	—	—	$6,410,958	$114,479	$139	$6,705,205
John Volpone	COO	$176,538	—	—	$6,410,958	$75,006	$4,985	$6,667,487
David Kirske	CFO	$194,192	$120,000	—	$4,181,040	$103,133	$901	$4,599,266
Paula Ragan	CEO	$420,170	—	$1,081,575	—	—	$1,138,824	$2,640,569

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Paula Ragan	CEO	$654,156	—	$312,962	$857,686	$305,818	$14,419	$2,145,041
Adam Mostafa	CFO	$510,000	$102,000	$137,703	$377,381	$179,520	$619	$1,307,223
Mark Baldry	CCO	$475,000	—	$137,703	$377,381	$167,200	$14,419	$1,171,703

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Paula Ragan	CEO	$620,053	—	$1,035,784	—	$375,132	$13,792	$2,044,761
Christophe Arbet-Engels	Chief Medical Officer	$179,590	$200,000	—	$1,257,135	—	$205	$1,636,930
Adam Mostafa	CFO	$486,192	—	$452,064	—	$214,000	$592	$1,152,848

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Paula Ragan	CEO	$583,481	$58,773	$476,904	$2,432,049	$308,557	$12,769	$3,872,533
Adam Mostafa	CFO	$458,973	$46,085	$226,800	$954,900	$193,555	$569	$1,880,882
Mary DiBiase	COO	$426,296	$42,793	$226,800	$954,900	$179,730	$12,769	$1,843,288

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Paula Ragan	CEO	$562,126	—	$1,258,272	—	$309,330	$11,600	$2,141,328
Adam Mostafa	CFO	$430,193	—	$723,518	—	$185,220	—	$1,338,931
Derek Meisner	Chief Legal Officer and Corporate Secretary	$428,173	—	$415,234	—	$184,338	$11,524	$1,039,269

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Paula Ragan	CEO	$543,400	—	$1,690,827	—	$271,700	$7,605	$2,513,532
Adam Mostafa	CFO	$400,000	—	$612,950	—	$163,600	—	$1,176,550
Derek Meisner	Chief Legal Officer and Corporate Secretary	$400,000	$67,500	$471,500	—	$162,400	$11,400	$1,112,800

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Paula Ragan	CEO	$492,276	—	$824,938	$893,460	$286,000	$1,177	$2,497,851
Michael Gray	CEO	$91,250	—	—	—	—	$1,048,572	$1,139,822
E. Lynne Kelley	M.D., FACS Former Chief Medical Officer	$280,968	—	—	$566,374	$121,005	$1,604	$969,951
Adam Mostafa	CFO	$372,275	—	$155,819	$168,771	$168,341	$1,025	$866,231

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Michael Gray	CEO	$405,193	$181,136	$1,030,000	$1,310,947	—	—	$2,927,276
Paula Ragan	CEO	$380,000	—	—	$407,577	$133,000	$450	$921,027
Adam Mostafa	CFO	$109,285	—	—	$480,789	$38,250	$90	$628,414

Executive changes

Person	Role	Change	Effective	Filed
Kelly Gold	Class II director	Appointed	2026-07-01	2026-07-01
Michael S. Wyzga	Class III director	Appointed	—	2026-05-12
Françoise De Craecker	Class III director	Appointed	—	2026-05-12
Gary J. Bridger, Ph.D.	Class III director	Appointed	—	2026-05-12

Key facts CIK 1501697 CUSIP 98420X202 13F (30d) 5 filings 5 filers Visit website Investor relations